ETF Holdings Breakdown of BLFS

News associated with BLFS

Dimensional Fund Advisors LP Purchases 40,416 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)

Dimensional Fund Advisors LP grew its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 4.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 887,008 shares of the medical equipment provider’s stock after purchasing an additional 40,416 shares during the quarter. Dimensional Fund […] - 2025-05-07 08:22:55

BioLife Solutions, Inc. (NASDAQ:BLFS) Receives $31.17 Average PT from Analysts

BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued ratings on the stock in the last […] - 2025-05-01 06:06:50

Envestnet Asset Management Inc. Has $5.16 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)

Envestnet Asset Management Inc. lifted its stake in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 18.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 198,695 shares of the medical equipment provider’s stock after acquiring an additional 31,167 shares […] - 2025-04-23 07:38:47

StockNews.com Downgrades BioLife Solutions (NASDAQ:BLFS) to Sell

BioLife Solutions (NASDAQ:BLFS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Monday. Other research analysts also recently issued reports about the stock. Benchmark reiterated a “buy” rating and set a $30.00 price objective on shares of BioLife Solutions in […] - 2025-04-02 05:20:53

Brokerages Set BioLife Solutions, Inc. (NASDAQ:BLFS) PT at $29.86

BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have issued a report on the stock […] - 2025-03-12 06:10:56

5 Low-Leverage Stocks to Buy Amid Volatile Market Sentiment

The crux of safe investment lies in choosing a company that is not burdened with debt. You may buy BLFS, BHLB, NVDA, GBX and EZPW. - 2025-03-10 13:58:00

Oppenheimer Asset Management Inc. Sells 9,146 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)

Oppenheimer Asset Management Inc. trimmed its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 35.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,763 shares of the medical equipment provider’s stock after selling 9,146 shares during the quarter. Oppenheimer Asset Management […] - 2025-03-06 11:05:09

Contrasting BioLife Solutions (NASDAQ:BLFS) and Vivani Medical (NASDAQ:VANI)

Vivani Medical (NASDAQ:VANI – Get Free Report) and BioLife Solutions (NASDAQ:BLFS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Volatility & Risk Vivani Medical has a […] - 2025-02-28 07:12:50

New York State Common Retirement Fund Acquires 10,836 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)

New York State Common Retirement Fund grew its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 4.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 260,315 shares of the medical equipment provider’s stock after purchasing an additional 10,836 shares during the period. New […] - 2025-02-27 08:51:01

BioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Up 5.8% in January

BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 3,310,000 shares, a growth of 5.8% from the December 31st total of 3,130,000 shares. Based on an average trading volume of 379,000 shares, the days-to-cover ratio […] - 2025-02-05 07:04:47

BLFS institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	34,654	USD 774,863
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	6,756	USD 151,064
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	87	USD 1,945
Total =		41,497	USD 927,872

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer